Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer

1996 ◽  
Vol 37 (6) ◽  
pp. 613-615 ◽  
Author(s):  
C. Gridelli ◽  
Antonio Rossi ◽  
Pasquale Incoronato ◽  
Giovanni Salvatore Bruni ◽  
Francesco Scognamiglio ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
High Dose ◽  
Small Cell Lung

scholarly journals Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV

1995 ◽  
Vol 72 (6) ◽  
pp. 1547-1550 ◽  
Author(s):  
M Bakker ◽  
HJM Groen ◽  
EF Smit ◽  
J Smeets ◽  
M Riggi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Stage Iiib ◽  
High Dose ◽  
Cancer Stage ◽  
Small Cell Lung

Phase I Study of Weekly Alternating Therapy with Irinotecan/Cisplatin and Etoposide/Cisplatin for Patients with Small-Cell Lung Cancer

2003 ◽  
Vol 5 (1) ◽  
pp. 40-45 ◽  
Author(s):  
Faye M. Johnson ◽  
Jonathan M. Kurie ◽  
Beverly O. Peeples ◽  
J. Jack Lee ◽  
Lei Feng ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung

A Phase I study of Nedaplatin (CDGP) and docetaxel (TXT) in patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽  
2000 ◽  
Vol 29 (1) ◽  
pp. 69
Author(s):  
J Saito ◽  
Y Nakai ◽  
S Koinumaru ◽  
T Matsuda ◽  
Y Saijo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document